Hydatiform mole natural history, complications and prognosis
|
Hydatiform mole Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hydatiform mole natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Hydatiform mole natural history, complications and prognosis |
|
FDA on Hydatiform mole natural history, complications and prognosis |
|
CDC on Hydatiform mole natural history, complications and prognosis |
|
Hydatiform mole natural history, complications and prognosis in the news |
|
Blogs on Hydatiform mole natural history, complications and prognosis |
|
Risk calculators and risk factors for Hydatiform mole natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Prognosis
More than 80% of hydatidiform moles are benign. The outcome after treatment is usually excellent. Close follow-up is essential. Highly effective means of contraception are recommended to avoid pregnancy for at least 6 to 12 months.
In 10 to 15% of cases, hydatidiform moles may develop into invasive moles. These may intrude so far into the uterine wall that hemorrhage or other complications develop. It is for this reason that a post-operative full abdominal and chest x-ray will often be requested.
In 2 to 3% of cases, hydatidiform moles may develop into choriocarcinoma, which is a malignant, rapidly-growing, and metastatic (spreading) form of cancer. Despite these factors which normally indicate a poor prognosis, the rate of cure after treatment with chemotherapy is high.
Over 90% of women with malignant, non-spreading cancer are able to survive and retain their ability to have children. In those with metastatic (spreading) cancer, remission remains at 75 to 85%, although the ability to have children is usually lost.